Highlights Mabion S.A.

Equities

MAB

PLMBION00016

Market Closed - Warsaw S.E. Other stock markets 09:25:55 05/07/2024 pm IST			5-day change	1st Jan Change
17 ^PLN	+0.12%		-1.28%	-6.34%

14/05	Mabion S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
16/04	Mabion S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Mabion S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05	CI
Mabion S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	16/04	CI
Mabion S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11	CI
Mabion S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	12/23/12	CI
Mabion S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	23/23/23	CI
Mabion S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	18/23/18	CI
Mabion Announces Extension of Deal with Novavax	06/23/06	CI
Mabion S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	24/22/24	CI
Mabion S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	30/22/30	CI
Mabion S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022	27/22/27	CI
Mabion S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	22/22/22	CI
Mabion S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	29/21/29	CI
Mabion S.A. Reports Earnings Results for the Second Quarter Ended June 30, 2021	16/21/16	CI
Mabion S A : Big pharma and private equity seek healthy returns in Europe's east	20/21/20	RE
Mabion S.A. Reports Earnings Results for the Full Year Ended December 31, 2020	01/21/01	CI
Stoxx Europe 600 : Polish Biotech Mabion Enters Deal To Manufacture Novavax COVID-19 Jab	04/21/04	MT
Mabion Biotech Signs Deal with Novavax on Covid-19 Vaccine Technology Transfer	03/21/03	CI
Mabion S.A. Reports Earnings Results for the Third Quarter Ended September 30, 2020	23/20/23	CI
Mabion S.A. Reports Earnings Results for the Second Quarter Ended June 30, 2020	23/20/23	CI
Mabion Signs Supply and Commercialization Agreement with Mylan Regarding Mabion CD20 for EU Mabion S.A	10/16/10	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Mabion S.A.

Equities

MAB

PLMBION00016

Highlights

Filters